NEW YORK, Oct. 17, 2016 -- TransPerfect Life Sciences, a leading provider of global development and commercialization solutions to the life sciences industry, today announced that Agility Clinical has implemented Trial Interactive as its electronic Trial Master File (eTMF).
|
|||
Agility Clinical is a California-based consulting and contract research organization (CRO) who specializes in assisting pre-clinical and clinical stage companies with complex trials and studies involving rare diseases.
Trial Interactive is an e-clinical platform used by leading biotechs, pharmas, and CROs in the product development process. As a web-based, 21 CFR Part 11-compliant platform, Trial Interactive eliminates the redundancies associated with paper-based study start-up and TMF management. Stakeholders have real-time access to clinical trial documentation, and travel and shipping costs associated with paper review and reconciliation are drastically reduced.
Agility chose Trial Interactive for its versatile functionality, with modules for e-feasibility, study start-up, eTMF, document management, and training/learning management. Trial Interactive offers Agility an end-to-end e-clinical solution to streamline their processes and increase transparency with their sponsor clients.
Agility Executive Vice President of Project Management and Clinical Operations, Kristi Clark says, “Use of an eTMF system provides a multitude of benefits to our clients and staff, including real-time access to study documents, consistency in naming and filing of regulatory documents, and increased efficiency as the need for manual tracking and filing is eliminated. We chose Trial Interactive because it is a cloud-based system which allows us accessibility to our documents from anywhere and gives our clients transparency into their TMF at all times. In addition, the system can be customized to better serve the needs of our clients while accommodating different study designs and document requirements.”
Michael Smyth, General Manager of TransPerfect Life Sciences Solutions, stated, “We were excited to be selected as the eTMF provider by Agility Clinical, a highly specialized CRO and consultancy with an excellent reputation. Since the launch of Trial Interactive nearly a decade ago, our goal has always been to assist our clients in maximizing TMF health and to enable them to function in a paperless environment that is user-friendly for stakeholders, no matter where they are.”
About TransPerfect Trial Interactive
TransPerfect’s Trial Interactive solution provides a collaborative web-based platform for study start-up and eTMF that enables sponsors, CROs, IRBs, central laboratories, and other vendors to maintain and update clinical trial documentation in a secure online environment. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of TransPerfect’s Life Sciences division, Trial Interactive is dedicated to working with clients on a global, collaborative level, supporting a wide range of requirements including e-feasibility, eTMF review/reconciliation, pharmacovigilance and safety management, endpoint adjudication, and product licensing and alliance management. For more information on Trial Interactive, please contact [email protected] or +1 212.400.8848, or visit www.trialinteractive.com.
About Agility Clinical
Agility is a niche CRO focused on the needs of pre-clinical and clinical stage companies and specializes in complex trials and rare diseases. The Agility team has an extensive track record conducting trials and preparing data for regulatory submissions leading to product approval. Founded in 2012 by an experienced executive team and employee-owned, Agility won the ROAR (Rare and Orphan Advocacy and Research) award for best CRO for two consecutive years against several well‑known CROs. Our team is experienced, efficient, and dependable, yet creative and committed to our clients and the patients they are trying to help. Agility has established operations in Carlsbad, CA.
Contact: Ryan Simper +1 212.689.5555 [email protected]


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



